Literature DB >> 20841413

Prolonged high-dose isoflurane for refractory status epilepticus: is it safe?

Jennifer E Fugate1, Joseph D Burns, Eelco F M Wijdicks, David O Warner, Christopher J Jankowski, Alejandro A Rabinstein.   

Abstract

Isoflurane is an alternative treatment for refractory status epilepticus. Little is known regarding human toxicities caused by isoflurane. We present 2 patients with prolonged refractory status epilepticus treated with high concentrations of isoflurane who developed signal abnormalities on magnetic resonance imaging. Patient 1 was treated with isoflurane for 85 days with 1975.2% concentration-hours. Patient 2 was treated with isoflurane for 34 days with 1382.4% concentration-hours. Serial brain magnetic resonance images in both showed progressive T2 signal hyperintensity involving thalamus and cerebellum, which improved after discontinuation of isoflurane. These cases suggest that isoflurane may be neurotoxic when used in high doses for long time periods.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20841413     DOI: 10.1213/ANE.0b013e3181f6da34

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  11 in total

Review 1.  Management of refractory status epilepticus in adults: still more questions than answers.

Authors:  Andrea O Rossetti; Daniel H Lowenstein
Journal:  Lancet Neurol       Date:  2011-10       Impact factor: 44.182

2.  Surpassing boundaries: volatile sedation in the NeuroICU.

Authors:  Federico Villa; Giuseppe Citerio
Journal:  Intensive Care Med       Date:  2012-09-28       Impact factor: 17.440

3.  Volatile isoflurane sedation in cerebrovascular intensive care patients using AnaConDa(®): effects on cerebral oxygenation, circulation, and pressure.

Authors:  Julian Bösel; Jan C Purrucker; Frank Nowak; Julian Renzland; Petra Schiller; Eva Benveniste Pérez; Sven Poli; Benjamin Brunn; Werner Hacke; Thorsten Steiner
Journal:  Intensive Care Med       Date:  2012-10-25       Impact factor: 17.440

Review 4.  Toxicity of inhaled agents after prolonged administration.

Authors:  Panumart Manatpon; W Andrew Kofke
Journal:  J Clin Monit Comput       Date:  2017-11-02       Impact factor: 2.502

5.  Isoflurane Use in the Treatment of Super-Refractory Status Epilepticus is Associated with Hippocampal Changes on MRI.

Authors:  Kristin M Ikeda; Robert Connors; Donald H Lee; Alexander G Khandji; Jan Claassen; G Bryan Young
Journal:  Neurocrit Care       Date:  2017-06       Impact factor: 3.210

Review 6.  Treatment of Generalized Convulsive Status Epilepticus in Pediatric Patients.

Authors:  Elizabeth L Alford; James W Wheless; Stephanie J Phelps
Journal:  J Pediatr Pharmacol Ther       Date:  2015 Jul-Aug

7.  Management of super-refractory status epilepticus with isoflurane and hypothermia.

Authors:  Agzam Zhumadilov; Charles P Gilman; Dmitriy Viderman
Journal:  Front Neurol       Date:  2015-01-28       Impact factor: 4.003

8.  Anesthetic management of a patient with Lennox-Gastaut syndrome with intractable epilepsy -a case report-.

Authors:  Mi-Na Park; Ji-Yeon Kim
Journal:  Korean J Anesthesiol       Date:  2013-10-24

9.  Refractory and Super-refractory Status Epilepticus.

Authors:  Debopam Samanta; Lisa Garrity; Ravindra Arya
Journal:  Indian Pediatr       Date:  2020-03-15       Impact factor: 1.411

10.  Treatment of Super-Refractory Status Epilepticus: A Review.

Authors:  Juan G Ochoa; Michelle Dougherty; Alex Papanastassiou; Barry Gidal; Ismail Mohamed; David G Vossler
Journal:  Epilepsy Curr       Date:  2021-03-10       Impact factor: 7.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.